Proactiveinvestors Australia Pfizer https://www.proactiveinvestors.com.au Proactiveinvestors Australia Pfizer RSS feed en Sun, 12 Jul 2020 08:52:37 +1000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Pfizer and BioNTech shares jump as early data from coronavirus vaccine trial cheers investors https://www.proactiveinvestors.com.au/companies/news/923236/pfizer-and-biontech-shares-jump-as-early-data-from-coronavirus-vaccine-trial-cheers-investors-923236.html Wed, 01 Jul 2020 17:33:00 +1000 https://www.proactiveinvestors.com.au/companies/news/923236/pfizer-and-biontech-shares-jump-as-early-data-from-coronavirus-vaccine-trial-cheers-investors-923236.html Pfizer’s coronavirus vaccine candidate enters first phase of US trials https://www.proactiveinvestors.com.au/companies/news/918854/pfizers-coronavirus-vaccine-candidate-enters-first-phase-of-us-trials-918854.html Tue, 05 May 2020 11:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/918854/pfizers-coronavirus-vaccine-candidate-enters-first-phase-of-us-trials-918854.html How much should a ‘blockbuster’ drug earn now? https://www.proactiveinvestors.com.au/companies/news/908861/how-much-should-a-blockbuster-drug-earn-now-908861.html Wed, 25 Dec 2019 08:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/908861/how-much-should-a-blockbuster-drug-earn-now-908861.html Pfizer stock climbs as drug giant raises 2019 guidance https://www.proactiveinvestors.com.au/companies/news/905854/pfizer-stock-climbs-as-drug-giant-raises-2019-guidance-905854.html Tue, 29 Oct 2019 14:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905854/pfizer-stock-climbs-as-drug-giant-raises-2019-guidance-905854.html Pharma stocks head south as Trump forces them to display drug prices in TV ads https://www.proactiveinvestors.com.au/companies/news/219995/pharma-stocks-head-south-as-trump-forces-them-to-display-drug-prices-in-tv-ads-219995.html Thu, 09 May 2019 14:40:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219995/pharma-stocks-head-south-as-trump-forces-them-to-display-drug-prices-in-tv-ads-219995.html Pfizer narrows full year guidance as third quarter earnings beat forecasts but revenues disappoint https://www.proactiveinvestors.com.au/companies/news/208117/pfizer-narrows-full-year-guidance-as-third-quarter-earnings-beat-forecasts-but-revenues-disappoint-208117.html Tue, 30 Oct 2018 11:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/208117/pfizer-narrows-full-year-guidance-as-third-quarter-earnings-beat-forecasts-but-revenues-disappoint-208117.html Pfizer's pipeline looks impressive and should grow further after 2020, says Oppenheimer analyst https://www.proactiveinvestors.com.au/companies/news/203511/pfizer-s-pipeline-looks-impressive-and-should-grow-further-after-2020-says-oppenheimer-analyst-203511.html Thu, 23 Aug 2018 16:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/203511/pfizer-s-pipeline-looks-impressive-and-should-grow-further-after-2020-says-oppenheimer-analyst-203511.html Pfizer 2Q earnings beat Street on higher sales of Prevnar vaccine, arthritis drug Xeljanz https://www.proactiveinvestors.com.au/companies/news/201933/pfizer-2q-earnings-beat-street-on-higher-sales-of-prevnar-vaccine-arthritis-drug-xeljanz-201933.html Tue, 31 Jul 2018 13:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/201933/pfizer-2q-earnings-beat-street-on-higher-sales-of-prevnar-vaccine-arthritis-drug-xeljanz-201933.html IPO Roundup: Fintech lender GreenSky, 7 more companies pricing shares this week https://www.proactiveinvestors.com.au/companies/news/197390/ipo-roundup-fintech-lender-greensky-7-more-companies-pricing-shares-this-week-197390.html Mon, 21 May 2018 14:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/197390/ipo-roundup-fintech-lender-greensky-7-more-companies-pricing-shares-this-week-197390.html Pfizer 1Q revenue misses analyst estimates as sales of Ibrance, Xeljanz disappoint https://www.proactiveinvestors.com.au/companies/news/196160/pfizer-1q-revenue-misses-analyst-estimates-as-sales-of-ibrance-xeljanz-disappoint-196160.html Tue, 01 May 2018 13:42:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196160/pfizer-1q-revenue-misses-analyst-estimates-as-sales-of-ibrance-xeljanz-disappoint-196160.html Pfizer is in talks to sell consumer unit including Chapstick to Proctor & Gamble, says CNBC https://www.proactiveinvestors.com.au/companies/news/194183/pfizer-is-in-talks-to-sell-consumer-unit-including-chapstick-to-proctor-gamble-says-cnbc-194183.html Tue, 03 Apr 2018 19:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/194183/pfizer-is-in-talks-to-sell-consumer-unit-including-chapstick-to-proctor-gamble-says-cnbc-194183.html Pfizer shares fall despite upbeat 2018 guidance and market beating fourth quarter numbers https://www.proactiveinvestors.com.au/companies/news/190843/pfizer-shares-fall-despite-upbeat-2018-guidance-and-market-beating-fourth-quarter-numbers-190843.html Tue, 30 Jan 2018 20:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190843/pfizer-shares-fall-despite-upbeat-2018-guidance-and-market-beating-fourth-quarter-numbers-190843.html Strong pneumonia vaccine sales help Pfizer to top Street estimates https://www.proactiveinvestors.com.au/companies/news/186509/strong-pneumonia-vaccine-sales-help-pfizer-to-top-street-estimates-186509.html Tue, 31 Oct 2017 14:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/186509/strong-pneumonia-vaccine-sales-help-pfizer-to-top-street-estimates-186509.html Pfizer ponders spinning off its Consumer Healthcare division https://www.proactiveinvestors.com.au/companies/news/185349/pfizer-ponders-spinning-off-its-consumer-healthcare-division-185349.html Tue, 10 Oct 2017 12:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185349/pfizer-ponders-spinning-off-its-consumer-healthcare-division-185349.html Pfizer, Amgen , Clovis Oncology and more - PRE-MARKET https://www.proactiveinvestors.com.au/companies/news/185345/pfizer-amgen-clovis-oncology-and-more-pre-market-185345.html Tue, 10 Oct 2017 12:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185345/pfizer-amgen-clovis-oncology-and-more-pre-market-185345.html FDA sends damning warning letter to Pfizer after misfiring EpiPens linked to deaths https://www.proactiveinvestors.com.au/companies/news/183679/fda-sends-damning-warning-letter-to-pfizer-after-misfiring-epipens-linked-to-deaths-183679.html Fri, 08 Sep 2017 12:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183679/fda-sends-damning-warning-letter-to-pfizer-after-misfiring-epipens-linked-to-deaths-183679.html Pfizer receives FDA approval for acute myeloid leukemia therapy https://www.proactiveinvestors.com.au/companies/news/183327/pfizer-receives-fda-approval-for-acute-myeloid-leukemia-therapy-183327.html Fri, 01 Sep 2017 19:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183327/pfizer-receives-fda-approval-for-acute-myeloid-leukemia-therapy-183327.html Pfizer quarterly revenue falls more than forecast on lower demand for Prevnar and Enbrel https://www.proactiveinvestors.com.au/companies/news/181789/pfizer-quarterly-revenue-falls-more-than-forecast-on-lower-demand-for-prevnar-and-enbrel-181789.html Tue, 01 Aug 2017 12:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181789/pfizer-quarterly-revenue-falls-more-than-forecast-on-lower-demand-for-prevnar-and-enbrel-181789.html Pfizer cuts losses on Brazil drug maker with sale for nominal sum https://www.proactiveinvestors.com.au/companies/news/180385/pfizer-cuts-losses-on-brazil-drug-maker-with-sale-for-nominal-sum-180385.html Wed, 05 Jul 2017 12:34:00 +1000 https://www.proactiveinvestors.com.au/companies/news/180385/pfizer-cuts-losses-on-brazil-drug-maker-with-sale-for-nominal-sum-180385.html Pfizer reveals easing of fourth quarter revenue https://www.proactiveinvestors.com.au/companies/news/172425/pfizer-reveals-easing-of-fourth-quarter-revenue-172425.html Tue, 31 Jan 2017 15:11:00 +1100 https://www.proactiveinvestors.com.au/companies/news/172425/pfizer-reveals-easing-of-fourth-quarter-revenue-172425.html Pfizer fined £84mln for epilepsy drug rip-off https://www.proactiveinvestors.com.au/companies/news/170105/pfizer-fined-84mln-for-epilepsy-drug-rip-off-170105.html Wed, 07 Dec 2016 08:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/170105/pfizer-fined-84mln-for-epilepsy-drug-rip-off-170105.html Pfizer trims 2016 profit forecast as it scraps cholesterol drug https://www.proactiveinvestors.com.au/companies/news/168355/pfizer-trims-2016-profit-forecast-as-it-scraps-cholesterol-drug-168355.html Tue, 01 Nov 2016 15:17:00 +1100 https://www.proactiveinvestors.com.au/companies/news/168355/pfizer-trims-2016-profit-forecast-as-it-scraps-cholesterol-drug-168355.html Pfizer, Etsy and eBay on brokers’ radars https://www.proactiveinvestors.com.au/companies/news/276271/pfizer-etsy-and-ebay-on-brokers-radars-26271.html Thu, 13 Oct 2016 19:16:00 +1100 https://www.proactiveinvestors.com.au/companies/news/276271/pfizer-etsy-and-ebay-on-brokers-radars-26271.html Pfizer can’t do without essential health, or innovation https://www.proactiveinvestors.com.au/companies/news/166467/pfizer-cant-do-without-essential-health-or-innovation-166467.html Mon, 26 Sep 2016 13:53:00 +1000 https://www.proactiveinvestors.com.au/companies/news/166467/pfizer-cant-do-without-essential-health-or-innovation-166467.html Pharma Pfizer unfazed after Jefferies trims price target https://www.proactiveinvestors.com.au/companies/news/127319/pharma-pfizer-unfazed-after-jefferies-trims-price-target-127319.html Mon, 20 Jun 2016 20:18:00 +1000 https://www.proactiveinvestors.com.au/companies/news/127319/pharma-pfizer-unfazed-after-jefferies-trims-price-target-127319.html Pfizer treatment passes second efficacy trial for psoriatic arthritis https://www.proactiveinvestors.com.au/companies/news/126832/pfizer-treatment-passes-second-efficacy-trial-for-psoriatic-arthritis-126832.html Tue, 07 Jun 2016 12:57:00 +1000 https://www.proactiveinvestors.com.au/companies/news/126832/pfizer-treatment-passes-second-efficacy-trial-for-psoriatic-arthritis-126832.html Pfizer a buy at lower levels, says Jefferies https://www.proactiveinvestors.com.au/companies/news/274696/pfizer-a-buy-at-lower-levels-says-jefferies-24696.html Thu, 07 Apr 2016 19:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/274696/pfizer-a-buy-at-lower-levels-says-jefferies-24696.html Pfizer Inc abandons $160bn Allergan PLC merger after inversion crackdown https://www.proactiveinvestors.com.au/companies/news/124479/pfizer-inc-abandons-160bn-allergan-plc-merger-after-inversion-crackdown-124479.html Wed, 06 Apr 2016 14:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/124479/pfizer-inc-abandons-160bn-allergan-plc-merger-after-inversion-crackdown-124479.html Trending: Pfizer tie up with Allergan catches a cold https://www.proactiveinvestors.com.au/companies/news/124464/trending-pfizer-tie-up-with-allergan-catches-a-cold-124464.html Tue, 05 Apr 2016 20:06:00 +1000 https://www.proactiveinvestors.com.au/companies/news/124464/trending-pfizer-tie-up-with-allergan-catches-a-cold-124464.html Pfizer Inc and Allergan PLC’s merger under threat by US Treasury https://www.proactiveinvestors.com.au/companies/news/124452/pfizer-inc-and-allergan-plcs-merger-under-threat-by-us-treasury-124452.html Tue, 05 Apr 2016 14:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/124452/pfizer-inc-and-allergan-plcs-merger-under-threat-by-us-treasury-124452.html Pfizer tops Q4 hopes but lowers guidance for 2016 https://www.proactiveinvestors.com.au/companies/news/122060/pfizer-tops-q4-hopes-but-lowers-guidance-for-2016-122060.html Tue, 02 Feb 2016 18:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/122060/pfizer-tops-q4-hopes-but-lowers-guidance-for-2016-122060.html Pfizer agrees US$150bn Allergan merger https://www.proactiveinvestors.com.au/companies/news/119592/pfizer-agrees-us150bn-allergan-merger-119592.html Mon, 23 Nov 2015 14:59:00 +1100 https://www.proactiveinvestors.com.au/companies/news/119592/pfizer-agrees-us150bn-allergan-merger-119592.html Pfizer tops Q3 profit estimates, lifts 2015 outlook https://www.proactiveinvestors.com.au/companies/news/116705/pfizer-tops-q3-profit-estimates-lifts-2015-outlook-116705.html Tue, 27 Oct 2015 12:34:00 +1100 https://www.proactiveinvestors.com.au/companies/news/116705/pfizer-tops-q3-profit-estimates-lifts-2015-outlook-116705.html Pfizer boosts 2015 outlook on Hospira purchase https://www.proactiveinvestors.com.au/companies/news/115253/pfizer-boosts-2015-outlook-on-hospira-purchase-115253.html Wed, 30 Sep 2015 17:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/115253/pfizer-boosts-2015-outlook-on-hospira-purchase-115253.html Pfizer says rheumatoid arthritis treatment shows improvement https://www.proactiveinvestors.com.au/companies/news/115252/pfizer-says-rheumatoid-arthritis-treatment-shows-improvement-115252.html Mon, 21 Sep 2015 17:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/115252/pfizer-says-rheumatoid-arthritis-treatment-shows-improvement-115252.html Pfizer loses Lyrica patent case in UK; shares drop https://www.proactiveinvestors.com.au/companies/news/115251/pfizer-loses-lyrica-patent-case-in-uk-shares-drop-115251.html Fri, 11 Sep 2015 15:49:00 +1000 https://www.proactiveinvestors.com.au/companies/news/115251/pfizer-loses-lyrica-patent-case-in-uk-shares-drop-115251.html Pfizer's drug patent deemed invalid by UK High Court https://www.proactiveinvestors.com.au/companies/news/110734/pfizer-s-drug-patent-deemed-invalid-by-uk-high-court-110734.html Fri, 11 Sep 2015 13:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/110734/pfizer-s-drug-patent-deemed-invalid-by-uk-high-court-110734.html Pfizer accused of overcharging NHS for epilepsy drug https://www.proactiveinvestors.com.au/companies/news/109739/pfizer-accused-of-overcharging-nhs-for-epilepsy-drug-109739.html Thu, 06 Aug 2015 12:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/109739/pfizer-accused-of-overcharging-nhs-for-epilepsy-drug-109739.html Pfizer's Q2 earnings beat expectations but suffer due to strength of US dollar https://www.proactiveinvestors.com.au/companies/news/115250/pfizer-s-q2-earnings-beat-expectations-but-suffer-due-to-strength-of-us-dollar-115250.html Tue, 28 Jul 2015 16:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/115250/pfizer-s-q2-earnings-beat-expectations-but-suffer-due-to-strength-of-us-dollar-115250.html Pfizer trims 2015 outlook on strong dollar, reports Q1 profit beat https://www.proactiveinvestors.com.au/companies/news/106442/pfizer-trims-2015-outlook-on-strong-dollar-reports-q1-profit-beat-61193.html Tue, 28 Apr 2015 13:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/106442/pfizer-trims-2015-outlook-on-strong-dollar-reports-q1-profit-beat-61193.html Pfizer to stop vaccine sales business in China after failing to obtain Prevnar license approval https://www.proactiveinvestors.com.au/companies/news/106198/pfizer-to-stop-vaccine-sales-business-in-china-after-failing-to-obtain-prevnar-license-approval-60816.html Thu, 02 Apr 2015 12:59:00 +1100 https://www.proactiveinvestors.com.au/companies/news/106198/pfizer-to-stop-vaccine-sales-business-in-china-after-failing-to-obtain-prevnar-license-approval-60816.html Pfizer's Lyrica pain drug fails FDA test for fibromyalgia in adolescents https://www.proactiveinvestors.com.au/companies/news/105904/pfizers-lyrica-pain-drug-fails-fda-test-for-fibromyalgia-in-adolescents-60412.html News of the test failure will add disappointment to what has already proven to be a difficult year for the New York-based drug maker, the biggest in the US, marked by patent expirations for key drugs and a stronger US dollar.

]]>
Fri, 13 Mar 2015 16:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/105904/pfizers-lyrica-pain-drug-fails-fda-test-for-fibromyalgia-in-adolescents-60412.html
Pfizer to acquire Hospira in $17 bln deal to boost biosimilar pipeline https://www.proactiveinvestors.com.au/companies/news/105379/pfizer-to-acquire-hospira-in-17-bln-deal-to-boost-biosimilar-pipeline-59699.html Thu, 05 Feb 2015 18:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/105379/pfizer-to-acquire-hospira-in-17-bln-deal-to-boost-biosimilar-pipeline-59699.html Pfizer 2015 outlook disappoints on patent expirations, stronger dollar https://www.proactiveinvestors.com.au/companies/news/105228/pfizer-2015-outlook-disappoints-on-patent-expirations-stronger-dollar-59491.html Tue, 27 Jan 2015 13:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/105228/pfizer-2015-outlook-disappoints-on-patent-expirations-stronger-dollar-59491.html Pfizer reports stronger Q3 profit on growing demand for cancer drugs in emerging markets https://www.proactiveinvestors.com.au/companies/news/103863/pfizer-reports-stronger-q3-profit-on-growing-demand-for-cancer-drugs-in-emerging-markets-57702.html Tue, 28 Oct 2014 14:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/103863/pfizer-reports-stronger-q3-profit-on-growing-demand-for-cancer-drugs-in-emerging-markets-57702.html Pfizer drops $118 bln bid for AstraZeneca https://www.proactiveinvestors.com.au/companies/news/101487/pfizer-drops-118-bln-bid-for-astrazeneca-54327.html U.S. drugmaker Pfizer Inc. today gave up its attempt to buy AstraZeneca for nearly $118 billion. The announcement came a week after AstraZeneca's board rejected the buyout proposal. Pfizer had until 5 p.m. local time in London today to extend a firm offer for AstraZeneca or declare its intent not to do so. Under U.K. law, Pfizer now cannot make another offer for six months.

]]>
Mon, 26 May 2014 18:06:00 +1000 https://www.proactiveinvestors.com.au/companies/news/101487/pfizer-drops-118-bln-bid-for-astrazeneca-54327.html
Pfizer slides after posting lower Q1 earnings and sales https://www.proactiveinvestors.com.au/companies/news/101146/pfizer-slides-after-posting-lower-q1-earnings-and-sales-53869.html Mon, 05 May 2014 12:47:00 +1000 https://www.proactiveinvestors.com.au/companies/news/101146/pfizer-slides-after-posting-lower-q1-earnings-and-sales-53869.html Pfizer edges lower after AstraZeneca rejects sweetened $106 bln bid https://www.proactiveinvestors.com.au/companies/news/101126/pfizer-edges-lower-after-astrazeneca-rejects-sweetened-106-bln-bid-53823.html Fri, 02 May 2014 13:32:00 +1000 https://www.proactiveinvestors.com.au/companies/news/101126/pfizer-edges-lower-after-astrazeneca-rejects-sweetened-106-bln-bid-53823.html Pfizer advances after confirming $98.7 bln bid for AstraZeneca https://www.proactiveinvestors.com.au/companies/news/101019/pfizer-advances-after-confirming-987-bln-bid-for-astrazeneca-53686.html Mon, 28 Apr 2014 11:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/101019/pfizer-advances-after-confirming-987-bln-bid-for-astrazeneca-53686.html Pfizer hits two-month high on positive results for breast cancer drug https://www.proactiveinvestors.com.au/companies/news/99708/pfizer-hits-two-month-high-on-positive-results-for-breast-cancer-drug-51765.html Mon, 03 Feb 2014 19:56:00 +1100 https://www.proactiveinvestors.com.au/companies/news/99708/pfizer-hits-two-month-high-on-positive-results-for-breast-cancer-drug-51765.html Pfizer's net income, revenue drops as it prepares for internal restructuring https://www.proactiveinvestors.com.au/companies/news/96577/pfizers-net-income-revenue-drops-as-it-prepares-for-internal-restructuring-46631.html Tue, 30 Jul 2013 15:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/96577/pfizers-net-income-revenue-drops-as-it-prepares-for-internal-restructuring-46631.html Pfizer reaches $2.2 bln settlement in Protonix patent case https://www.proactiveinvestors.com.au/companies/news/95569/pfizer-reaches-22-bln-settlement-in-protonix-patent-case--44927.html Wed, 12 Jun 2013 14:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/95569/pfizer-reaches-22-bln-settlement-in-protonix-patent-case--44927.html Pfizer lowers 2013 outlook, posts weaker Q1 profit, sales; shares fall https://www.proactiveinvestors.com.au/companies/news/94617/pfizer-lowers-2013-outlook-posts-weaker-q1-profit-sales-shares-fall-43287.html Tue, 30 Apr 2013 13:09:00 +1000 https://www.proactiveinvestors.com.au/companies/news/94617/pfizer-lowers-2013-outlook-posts-weaker-q1-profit-sales-shares-fall-43287.html Pfizer shares rise as Q4 results top views on sale of nutrition unit https://www.proactiveinvestors.com.au/companies/news/92702/pfizer-shares-rise-as-q4-results-top-views-on-sale-of-nutrition-unit-39968.html Tue, 29 Jan 2013 14:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/92702/pfizer-shares-rise-as-q4-results-top-views-on-sale-of-nutrition-unit-39968.html Pfizer to cut 20% of sales force - REPORT https://www.proactiveinvestors.com.au/companies/news/92044/pfizer-to-cut-20-of-sales-force-report-38797.html Wed, 19 Dec 2012 13:44:00 +1100 https://www.proactiveinvestors.com.au/companies/news/92044/pfizer-to-cut-20-of-sales-force-report-38797.html Pfizer cuts Viagra costs in Canada after generics legal challenge https://www.proactiveinvestors.com.au/companies/news/91421/pfizer-cuts-viagra-costs-in-canada-after-generics-legal-challenge-37672.html Thu, 22 Nov 2012 18:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/91421/pfizer-cuts-viagra-costs-in-canada-after-generics-legal-challenge-37672.html Pfizer Q3 earnings dented by loss of Lipitor exclusivity https://www.proactiveinvestors.com.au/companies/news/90880/pfizer-q3-earnings-dented-by-loss-of-lipitor-exclusivity-36778.html Drugs giant Pfizer's (NYSE:PFE) third-quarter earnings dropped 14 per cent Thursday as the end of U.S. exclusivity for blockbuster cholesterol drug Lipitor led to lower sales.

]]>
Thu, 01 Nov 2012 12:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/90880/pfizer-q3-earnings-dented-by-loss-of-lipitor-exclusivity-36778.html
UPDATE: Hargreaves Lansdown investors run for cover as New York braces for Hurricane Sandy https://www.proactiveinvestors.com.au/companies/news/90781/update-hargreaves-lansdown-investors-run-for-cover-as-new-york-braces-for-hurricane-sandy-36602.html Mon, 29 Oct 2012 13:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/90781/update-hargreaves-lansdown-investors-run-for-cover-as-new-york-braces-for-hurricane-sandy-36602.html Pfizer Q2 net rises 25% but Lipitor sales slide https://www.proactiveinvestors.com.au/companies/news/88333/pfizer-q2-net-rises-25-but-lipitor-sales-slide-32685.html Tue, 31 Jul 2012 13:03:00 +1000 https://www.proactiveinvestors.com.au/companies/news/88333/pfizer-q2-net-rises-25-but-lipitor-sales-slide-32685.html Pfizer, Ranbaxy sued by retailers for generic Lipitor delay https://www.proactiveinvestors.com.au/companies/news/87639/pfizer-ranbaxy-sued-by-retailers-for-generic-lipitor-delay-31562.html Fri, 06 Jul 2012 12:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/87639/pfizer-ranbaxy-sued-by-retailers-for-generic-lipitor-delay-31562.html Pfizer, Protalix's genetic treatment denied EU approval https://www.proactiveinvestors.com.au/companies/news/87290/pfizer-protalixs-genetic-treatment-denied-eu-approval-30910.html Fri, 22 Jun 2012 16:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/87290/pfizer-protalixs-genetic-treatment-denied-eu-approval-30910.html Drugmaker Pfizer's Q1 profit falls 19% https://www.proactiveinvestors.com.au/companies/news/85787/drugmaker-pfizers-q1-profit-falls-19-28487.html Tue, 01 May 2012 12:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/85787/drugmaker-pfizers-q1-profit-falls-19-28487.html Pfizer sells nutrition business to Nestlé for $11.85 bln https://www.proactiveinvestors.com.au/companies/news/85559/pfizer-sells-nutrition-business-to-nestl-for-1185-bln-28063.html Mon, 23 Apr 2012 13:51:00 +1000 https://www.proactiveinvestors.com.au/companies/news/85559/pfizer-sells-nutrition-business-to-nestl-for-1185-bln-28063.html Viagra maker Pfizer's Q4 profits droop but beat estimates https://www.proactiveinvestors.com.au/companies/news/83279/viagra-maker-pfizers-q4-profits-droop-but-beat-estimates-24245.html Viagra maker Pfizer (NYSE:PFE) Tuesday posted a fourth-quarter profit of $1.44 billion, or 19 cents per share, down from $2.89 billion, or 36 cents per share, a year earlier.

]]>
Tue, 31 Jan 2012 11:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/83279/viagra-maker-pfizers-q4-profits-droop-but-beat-estimates-24245.html
Pfizer reports positive results from anti-addiction study of Embeda https://www.proactiveinvestors.com.au/companies/news/82411/pfizer-reports-positive-results-from-anti-addiction-study-of-embeda-22832.html Thu, 22 Dec 2011 16:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/82411/pfizer-reports-positive-results-from-anti-addiction-study-of-embeda-22832.html Pfizer Q3 earnings soar on Capsugel sale, full year forecast raised https://www.proactiveinvestors.com.au/companies/news/81031/pfizer-q3-earnings-soar-on-capsugel-sale-full-year-forecast-raised-20398.html Tue, 01 Nov 2011 13:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/81031/pfizer-q3-earnings-soar-on-capsugel-sale-full-year-forecast-raised-20398.html Will RNAi Therapeutics Ever Succeed? Roche, Pfizer, Abbott, Merck, Novartis trim commitments https://www.proactiveinvestors.com.au/companies/news/80573/will-rnai-therapeutics-ever-succeed-roche-pfizer-abbott-merck-novartis-trim-commitments-19679.html Last November, Roche dropped out of RNAi research after $500 million in investments over the previous three years. Pfizer and Abbott announced in February they were both cutting their RNAi drug discovery programs. On July 29, Merck shut its San Francisco RNAi research facility

]]>
Sat, 15 Oct 2011 12:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/80573/will-rnai-therapeutics-ever-succeed-roche-pfizer-abbott-merck-novartis-trim-commitments-19679.html
Pfizer achieves all endpoints in phase 3 menopause drug study https://www.proactiveinvestors.com.au/companies/news/80010/pfizer-achieves-all-endpoints-in-phase-3-menopause-drug-study-18725.html Thu, 22 Sep 2011 15:36:00 +1000 https://www.proactiveinvestors.com.au/companies/news/80010/pfizer-achieves-all-endpoints-in-phase-3-menopause-drug-study-18725.html Pfizer's kidney cancer drug to be reviewed by FDA https://www.proactiveinvestors.com.au/companies/news/78332/pfizers-kidney-cancer-drug-to-be-reviewed-by-fda-15826.html Tue, 28 Jun 2011 15:03:00 +1000 https://www.proactiveinvestors.com.au/companies/news/78332/pfizers-kidney-cancer-drug-to-be-reviewed-by-fda-15826.html Pfizer and Pain Therapeutics' pain killer rejected by FDA https://www.proactiveinvestors.com.au/companies/news/78288/pfizer-and-pain-therapeutics-pain-killer-rejected-by-fda-15754.html Fri, 24 Jun 2011 18:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/78288/pfizer-and-pain-therapeutics-pain-killer-rejected-by-fda-15754.html Pfizer meets primary goal of phase 3 trial for drug to treat spinal cord injury pain https://www.proactiveinvestors.com.au/companies/news/78194/pfizer-meets-primary-goal-of-phase-3-trial-for-drug-to-treat-spinal-cord-injury-pain-15624.html Tue, 21 Jun 2011 15:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/78194/pfizer-meets-primary-goal-of-phase-3-trial-for-drug-to-treat-spinal-cord-injury-pain-15624.html Pfizer and Acura receive US FDA approval for Oxecta immediate-release pain killer https://www.proactiveinvestors.com.au/companies/news/78186/pfizer-and-acura-receive-us-fda-approval-for-oxecta-immediate-release-pain-killer-15606.html Mon, 20 Jun 2011 18:32:00 +1000 https://www.proactiveinvestors.com.au/companies/news/78186/pfizer-and-acura-receive-us-fda-approval-for-oxecta-immediate-release-pain-killer-15606.html Pfizer, Medivation's phase 3 study for Huntington's disease drug fails https://www.proactiveinvestors.com.au/companies/news/77105/pfizer-medivations-phase-3-study-for-huntingtons-disease-drug-fails-13755.html Mon, 11 Apr 2011 14:36:00 +1000 https://www.proactiveinvestors.com.au/companies/news/77105/pfizer-medivations-phase-3-study-for-huntingtons-disease-drug-fails-13755.html Pfizer to sell Capsugel to KKR for $2.4bn https://www.proactiveinvestors.com.au/companies/news/76978/pfizer-to-sell-capsugel-to-kkr-for-24bn--13546.html Mon, 04 Apr 2011 13:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/76978/pfizer-to-sell-capsugel-to-kkr-for-24bn--13546.html Pfizer meets primary goal of phase 3 study for rheumatoid arthritis https://www.proactiveinvestors.com.au/companies/news/76531/pfizer-meets-primary-goal-of-phase-3-study-for-rheumatoid-arthritis-12737.html Fri, 04 Mar 2011 13:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/76531/pfizer-meets-primary-goal-of-phase-3-study-for-rheumatoid-arthritis-12737.html Pfizer expands presence in dietary supplements through acquisition of Ferrosan’s healthcare business https://www.proactiveinvestors.com.au/companies/news/76118/pfizer-expands-presence-in-dietary-supplements-through-acquisition-of-ferrosans-healthcare-business-12068.html Mon, 07 Feb 2011 13:19:00 +1100 https://www.proactiveinvestors.com.au/companies/news/76118/pfizer-expands-presence-in-dietary-supplements-through-acquisition-of-ferrosans-healthcare-business-12068.html Pfizer To Pay $14 Million To Use Santaris Pharma’s Drug Development Technology https://www.proactiveinvestors.com.au/companies/news/75541/pfizer-to-pay-14-million-to-use-santaris-pharmas-drug-development-technology--11149.html Tue, 04 Jan 2011 18:42:00 +1100 https://www.proactiveinvestors.com.au/companies/news/75541/pfizer-to-pay-14-million-to-use-santaris-pharmas-drug-development-technology--11149.html Pfizer recalls lung drug Thelin and ends clinical studies due liver damage risk https://www.proactiveinvestors.com.au/companies/news/75333/pfizer-recalls-lung-drug-thelin-and-ends-clinical-studies-due-liver-damage-risk--10774.html Fri, 10 Dec 2010 20:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/75333/pfizer-recalls-lung-drug-thelin-and-ends-clinical-studies-due-liver-damage-risk--10774.html Pfizer's Sutent drug approved in Europe for rare form of advanced pancreatic cancer https://www.proactiveinvestors.com.au/companies/news/75181/pfizers-sutent-drug-approved-in-europe-for-rare-form-of-advanced-pancreatic-cancer-10545.html Thu, 02 Dec 2010 20:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/75181/pfizers-sutent-drug-approved-in-europe-for-rare-form-of-advanced-pancreatic-cancer-10545.html Pfizer reports positive results from phase 3 trial for advanced kidney cancer drug https://www.proactiveinvestors.com.au/companies/news/74953/pfizer-reports-positive-results-from-phase-3-trial-for-advanced-kidney-cancer-drug-10207.html Fri, 19 Nov 2010 18:48:00 +1100 https://www.proactiveinvestors.com.au/companies/news/74953/pfizer-reports-positive-results-from-phase-3-trial-for-advanced-kidney-cancer-drug-10207.html Pfizer To Acquire King Pharmaceuticals For $3.6 Billion Cash https://www.proactiveinvestors.com.au/companies/news/74249/pfizer-to-acquire-king-pharmaceuticals-for-36-billion-cash-9115.html Tue, 12 Oct 2010 19:16:00 +1100 https://www.proactiveinvestors.com.au/companies/news/74249/pfizer-to-acquire-king-pharmaceuticals-for-36-billion-cash-9115.html Pfizer's phase 2 results for psoriasis drug meet primary endpoint https://www.proactiveinvestors.com.au/companies/news/74199/-pfizers-phase-2-results-for-psoriasis-drug-meet-primary-endpoint-9027.html Thu, 07 Oct 2010 20:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/74199/-pfizers-phase-2-results-for-psoriasis-drug-meet-primary-endpoint-9027.html Pfizer and Debiopharm seal co-development deal for melanoma treatment https://www.proactiveinvestors.com.au/companies/news/71850/pfizer-and-debiopharm-seal-co-development-deal-for-melanoma-treatment-3520.html Thu, 07 Jan 2010 20:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/71850/pfizer-and-debiopharm-seal-co-development-deal-for-melanoma-treatment-3520.html Pfizer to collaborate with India's Arcolab to commercialise injectables in the US https://www.proactiveinvestors.com.au/companies/news/71841/pfizer-to-collaborate-with-indias-arcolab-to-commercialise-injectables-in-the-us-3492.html Wed, 06 Jan 2010 20:13:00 +1100 https://www.proactiveinvestors.com.au/companies/news/71841/pfizer-to-collaborate-with-indias-arcolab-to-commercialise-injectables-in-the-us-3492.html Autonomy Seals License Agreement With Pfizer https://www.proactiveinvestors.com.au/companies/news/71113/autonomy-seals-license-agreement-with-pfizer--2518.html Mon, 28 Sep 2009 12:57:00 +1000 https://www.proactiveinvestors.com.au/companies/news/71113/autonomy-seals-license-agreement-with-pfizer--2518.html GlaxoSmithKline and Pfizer to create specialist HIV company https://www.proactiveinvestors.com.au/companies/news/70178/glaxosmithkline-and-pfizer-to-create-specialist-hiv-company-1297.html Thu, 16 Apr 2009 16:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/70178/glaxosmithkline-and-pfizer-to-create-specialist-hiv-company-1297.html